Results 211 to 220 of about 86,115 (291)

High loss to follow-up on a bedaquiline-based regimen for rifampicin-resistant TB. [PDF]

IJTLD Open
Idowu F, Decroo T, Mesic A.
europepmc   +1 more source

Potential contribution of biomass gasification‐based technology in energy transition: a technical review coupled with bibliometric studies

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biomass gasification technology has been extensively researched around the world; however, there is a need to evaluate the current research landscape and evolutionary direction of research in the broader context of energy transition. A systematic bibliometric analysis of the Web of Science database was performed for articles that fall within ...
Olasunkanmi Opeoluwa Adeoye, Electo Eduardo Silva Lora, Rubenildo Vieira Andrade, Leonardo Peña Pupo, René Lesme Jaén, Osvaldo José Venturini   +5 more
wiley   +1 more source

Patient Perceptions of Delays in Audiology Services in Johannesburg: A Secondary Analysis of Waiting Times and Alternative Service Models. [PDF]

J Eval Clin Pract
Khoza-Shangase K, Munyembate TJ.
europepmc   +1 more source

Comparative field‐scale assessment of TLUD and Kon‐Tiki biochar systems: agronomic performance and net CO2e‐based techno‐economics

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Post‐harvest agricultural residues in Latin America are commonly underutilized, leading to greenhouse gas emissions and lost opportunities for bio‐based value creation. This study tests the hypothesis that decentralized, farmer‐scale pyrolysis technologies can deliver comparable agronomic benefits while exhibiting distinct techno‐economic and ...
Juan F. Saldarriaga, Thomas Käslin, Enara Fernández, Maider Amutio, Gartzen López, Laura Santamaria, Nausika Querejeta, Julián E. López   +7 more
wiley   +1 more source

Decentralising TB services for children: quality of care is fundamental. [PDF]

IJTLD Open
Graham SM, Zawedde-Muyanja S, Palmer M, Dlodlo RA.   +3 more
europepmc   +1 more source

Décentralisation [PDF]

Giappiconi, Thierry
core  

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Municipal officials' perspectives on challenges and opportunities in shaping urban built environments for active living in Thailand: a qualitative study. [PDF]

BMJ Glob Health
Topothai T, Topothai C, Petrunoff NA, Tangcharoensathien V, Suphanchaimat R, Müller-Riemenschneider F.   +5 more
europepmc   +1 more source

Integrating secondary prevention of rheumatic heart disease into the primary healthcare system in Northern Uganda. [PDF]

BMJ Glob Health
Minja NW, Pulle J, Rwebembera J, Ollberding NJ, Fall N, Atala J, Kamarembo J, Oyella L, Odong F, de Loizaga SR, Nakagaayi D, Sarnacki R, Dexheimer JW, Sable C, Longenecker CT, Okello E, Beaton AZ, Watkins DA, Danforth KM.   +18 more
europepmc   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source